Shawn Moaddeb

MiCardia Corp. designs, develops, and commercializes implantable medical devices. The firm offers implantable devices for the treatment of heart diseases, such as mitral valve regurgitation and congestive heart failure. It also provides enCor, an annuloplasty device that corrects residual mitral regurgitation on a beating heart. The company was founded in November 2004 by Michael R. Henson, Shawn Moaddeb and Samuel M. Shaolian and is headquartered in Irvine, CA.

St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN.

Ellipse Technologies, Inc. develops and commercializes implants for spinal and orthopedic applications. It designs, develop and commercialize non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. The company was founded by Samuel M. Shaolian and Shawn Moaddeb on June 30, 2005 and is headquartered in Aliso Viejo, CA.

Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA.

Allevion Therapeutics, Inc. develops and operates software platform for monitoring. It develops wearable non-invasive multi-modal smart energy-based system for treating essential tremor with continuous tremor monitoring adaptive sensor. The company is headquartered in Delaware.

SV-Medtech, Inc. engages in operation of a biotechnology firm. The company was founded in 2017 and is headquartered in Livermore, CA.

Adventus Ventures LLC (Adventus Ventures) is a venture capital firm founded in 2017 by Shawn Moaddeb and James Hill. The firm is headquartered in Irvine, California.

Temari Medical, Inc. develops the next generation cerebral aneurysm embolic protection system providing better treatment options. The company is headquartered in United States.